Cancer of the Cervix

2

Review clinical trials related to Cancer of the Cervix. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer

Advanced cervical cancer patients treated with standard of care (SOC) chemoradiation plus glutaminase inhibition with telaglenastat (CB-839) will have increased progression-free survival (PFS) compared to historical rates for patients receiving SOC chemoradiation alone.

Participants needed: 42
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Washington University School of MedicineUpdated: Mar 13, 2026Locations: 1
Eligibility criteria

Patient age ≥ 18 years. [+15]

Patient has another concurrent active invasive malignancy. [+13]

Status: Recruiting

MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial

This study is a dynamically adjustable prospective longitudinal study designed to capture biospecimen (biopsy, blood, surgical) and multimodal treatment-related data (imaging, dosimetry, clinical) before, during, and after treatment with definitive-intent chemoradiotherapy for patients with locally advanced cervical and pancreatic cancer.

Participants needed: 60
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Washington University School of MedicineUpdated: Nov 12, 2025Locations: 1
Eligibility criteria

Cervical cancer [+4]

Any issue (medical, anatomic, other) that might preclude safe acquisition of bio...